Pharmstandard unveils Net Profit of $73 million for 1H 2008
Russian drugmaker Pharmstandard has reported an 83% jump in Net Profit for 1H 2008 to $73 million under IFRS.
EBITDA came in at $110 million, up 62%, on Revenues of $259 million, up 40%.
The company highlighted strong sales of major products, plus the addition of 8 new products to their range, as well as a continued focus on effectively managing costs, as key drivers for the results.
You can share this story on social media:
Follow RT on
Dear readers! Thank you for your vibrant engagement with our content and for sharing your points of view. Please note that we have switched to a new commenting system. To leave comments, you will need to register. We are working on some adjustments so if you have questions or suggestions feel free to send them to feedback@rttv.ru. Please check our commenting policy
